Viewing StudyNCT06399393



Ignite Creation Date: 2024-05-06 @ 8:28 PM
Last Modification Date: 2024-05-06 @ 8:28 PM
Study NCT ID: NCT06399393
Status: Recruiting
Last Update Posted: May 3 2024
First Post: May 1 2024

Brief Title: A Study to Compare the Efficacy and Safety of Idecabtagene Vicleucel With Lenalidomide Maintenance Therapy Versus Lenalidomide Maintenance Therapy Alone in Adult Participants With Newly Diagnosed Multiple Myeloma Who Have Suboptimal Response After Autologous Stem Cell Transplantation
Sponsor:
Organization: Celgene

Study Design

Study Type: Interventional
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 618
Enrollment Type: Anticipated
Design Primary Purpose:
Design Masking:
Phases:
Name
Phase 3
Observational Models:
Time Perspective List:
Who Masked List: